【结 构 式】 |
【分子编号】17764 【品名】N-Carbobenzyloxyglycine; 2-[[(benzyloxy)carbonyl]amino]acetic acid 【CA登记号】1138-80-3 |
【 分 子 式 】C10H11NO4 【 分 子 量 】209.20168 【元素组成】C 57.41% H 5.3% N 6.7% O 30.59% |
合成路线1
该中间体在本合成路线中的序号:(I)Benzyloxycarbonylglycine (I) was coupled with N-hydroxysuccinimide in the presence of dicyclohexylcarbodiimide (DCC), and the resulting succinimidyl active ester (II) was condensed with dimiristylamine (III) to afford amide (IV). The benzyloxycarbonyl group was then removed by hydrogenolysis in the presence of palladium on carbon to yield amine (V). Coupling of this amine with Boc-protected L-arginine (VI) in the presence of diisopropylcarbodiimide (DIC) gave dipeptide (VII). Finally, partial deprotection of Boc groups with hydrochloric acid in dioxane provided the title compound.
【1】 Lewis, J.G.; et al.; A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc Natl Acad Sci USA 1996, 93, 8, 3177. |
【2】 Deprince, R.B.; Facchine, K.L.; Lewis, G.S.; Lewis, J.G.; Lin, K.-Y.; Matteucci, M.D.; Mook, R.A. Jr.; Wagner, R.W. (Gilead Sciences Inc.; Glaxo Wellcome plc); Cationic lipids for delivery of nucleic acids to cells. WO 9601841 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17764 | N-Carbobenzyloxyglycine; 2-[[(benzyloxy)carbonyl]amino]acetic acid | 1138-80-3 | C10H11NO4 | 详情 | 详情 |
(II) | 17765 | benzyl 2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethylcarbamate; Z-glycine N-succinimidyl ester | 2899-60-7 | C14H14N2O6 | 详情 | 详情 |
(III) | 17766 | DITETRADECYLAMINE; N-tetradecyl-1-tetradecanamine; N,N-ditetradecylamine | 17361-44-3 | C28H59N | 详情 | 详情 |
(IV) | 17767 | benzyl 2-(ditetradecylamino)-2-oxoethylcarbamate | C38H68N2O3 | 详情 | 详情 | |
(V) | 17768 | 2-amino-N,N-ditetradecylacetamide | C30H62N2O | 详情 | 详情 | |
(VI) | 17769 | (2S)-2-[(tert-butoxycarbonyl)amino]-5-[(tert-butoxycarbonyl)[imino(methylamino)methyl]amino]pentanoic acid | C17H32N4O6 | 详情 | 详情 | |
(VII) | 17770 | tert-butyl (4S)-4-[(tert-butoxycarbonyl)amino]-5-[[2-(ditetradecylamino)-2-oxoethyl]amino]-5-oxopentyl[[(tert-butoxycarbonyl)amino](imino)methyl]carbamate | C51H98N6O8 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(VI)Condensation of the secondary amine (I) with N5-Boc-N2-Z-ornithine (II) using EDC provided the acetal amide (III), and subsequent acid-catalyzed intramolecular cyclization of (III) in hot toluene gave rise to the pyrazinone (IV). Catalytic hydrogenation of the double bond with concomitant hydrogenolysis of the benzyloxycarbonyl group of (IV) provided the 1,3-substituted-2-oxopiperazine (V). This was condensed with Z-glycine (VI) to give amide (VII). Then, acid cleavage of the tert-butyl ester and N-Boc protecting groups of (VII) provided (VIII). The N-benzyloxycarbonyl group of (VIII) was subsequently removed by hydrogenolysis, yielding diamine (IX). Finally, acylation of (IX) with the imido ester of 4-guanidinobenzoic acid (X) furnished the title bis(4-guanidinobenzamide).
【1】 Kitamura, S.; et al.; Potent dibasic GPIIb/IIIA antagonists with reduces prolongation of bleeding time: Synthesis and pharmacological evaluation of 2-oxopiperazine. J Med Chem 2001, 44, 15, 2438. |
【2】 Fukushi, H.; Naka, T.; Terashita, Z.; Miyawaki, T. (Takeda Chemical Industries, Ltd.); Piperazinones useful as inhibitors of platelet aggregation. EP 0822931; JP 1997316059; US 5935963; US 6020334; WO 9633982 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50632 | tert-butyl 2-[(2,2-dimethoxyethyl)amino]acetate | C10H21NO4 | 详情 | 详情 | |
(II) | 50190 | (2S)-2-[[(benzyloxy)carbonyl]amino]-5-[(tert-butoxycarbonyl)amino]pentanoic acid | C18H26N2O6 | 详情 | 详情 | |
(III) | 50633 | tert-butyl 2-[[(2S)-2-[[(benzyloxy)carbonyl]amino]-5-[(tert-butoxycarbonyl)amino]pentanoyl](2,2-dimethoxyethyl)amino]acetate | C28H45N3O9 | 详情 | 详情 | |
(IV) | 50634 | benzyl (2S)-2-[3-[(tert-butoxycarbonyl)amino]propyl]-4-[2-(tert-butoxy)-2-oxoethyl]-3-oxo-3,4-dihydro-1(2H)-pyrazinecarboxylate | C26H37N3O7 | 详情 | 详情 | |
(V) | 50635 | tert-butyl 2-((3S)-3-[3-[(tert-butoxycarbonyl)amino]propyl]-2-oxopiperazinyl)acetate | C18H33N3O5 | 详情 | 详情 | |
(VI) | 17764 | N-Carbobenzyloxyglycine; 2-[[(benzyloxy)carbonyl]amino]acetic acid | 1138-80-3 | C10H11NO4 | 详情 | 详情 |
(VII) | 50639 | tert-butyl 2-((3S)-4-(2-[[(benzyloxy)carbonyl]amino]acetyl)-3-[3-[(tert-butoxycarbonyl)amino]propyl]-2-oxopiperazinyl)acetate | C28H42N4O8 | 详情 | 详情 | |
(VIII) | 50636 | 2-[(3S)-3-(3-aminopropyl)-4-(2-[[(benzyloxy)carbonyl]amino]acetyl)-2-oxopiperazinyl]acetic acid | C19H26N4O6 | 详情 | 详情 | |
(IX) | 50637 | 2-[(3S)-4-(2-aminoacetyl)-3-(3-aminopropyl)-2-oxopiperazinyl]acetic acid | C11H20N4O4 | 详情 | 详情 | |
(X) | 50638 | N-(4-[[(3,5-dioxo-4-azatricyclo[5.2.1.0(2,6)]dec-8-en-4-yl)oxy]carbonyl]phenyl)guanidine | C17H16N4O4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(XIX)The pentaamino compound (XVIII) was coupled with N-(benzyloxycarbonyl)glycine (XIX) employing EDC and HOBt to afford penta amide (XX). The carbobenzoy protecting groups of (XX) were then removed by hydrogenation over PtO2 to give (XXI). Finally, installation of the guanidino groups in (XXI) was carried out by condensation with N,N'-di(carbobenzoxy)-S-methylisothiourea (XXII), followed by hydrogenolysis of the carbobenzoxy groups.
【1】 Xuereb, H.; et al.; Design of an Oligosaccharide Scaffold that binds in the minor groove of DNA. J Am Chem Soc 2000, 122, 9, 1883-90. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(XVIII) | 40234 | C82H106N10O26 | 详情 | 详情 | ||
(XIX) | 17764 | N-Carbobenzyloxyglycine; 2-[[(benzyloxy)carbonyl]amino]acetic acid | 1138-80-3 | C10H11NO4 | 详情 | 详情 |
(XX) | 40235 | C42H76N10O16 | 详情 | 详情 | ||
(XXI) | 40236 | ethyl (2E,4E)-2,4-hexadienoate | 2396-84-1 | C8H12O2 | 详情 | 详情 |
(XXII) | 32861 | benzyl (E)-[[(benzyloxy)carbonyl]amino](methylsulfanyl)methylidenecarbamate | C18H18N2O4S | 详情 | 详情 |